Showing 1,701 - 1,720 results of 3,189 for search '"vaccines"', query time: 0.06s Refine Results
  1. 1701

    The structural basis of protective and nonprotective human monoclonal antibodies targeting the parainfluenza virus type 3 hemagglutinin-neuraminidase by Rose J. Miller, Ian A. Durie, Aaron D. Gingerich, Mohamed A. Elbehairy, Abigail G. Branch, Riley G. Davis, Nada Abbadi, Melinda A. Brindley, Jarrod J. Mousa

    Published 2024-12-01
    “…Abstract Parainfluenza virus 3 (PIV3) infection poses a substantial risk to vulnerable groups including infants, the elderly, and immunocompromised individuals, and lacks effective treatments or vaccines. This study focuses on targeting the hemagglutinin-neuraminidase (HN) protein, a structural glycoprotein of PIV3 critical for viral infection and egress. …”
    Get full text
    Article
  2. 1702

    COVID-19: Understanding the New Variants of Concern by Ke-Yan Loo, Vengadesh Letchumanan

    Published 2022-12-01
    “…The first variant was Alpha, followed by the discovery of Beta, Gamma, Delta, and Omicron, being the latest variant of concern. Although vaccines were distributed worldwide to reduce the severity of the disease when infected with SARS-CoV-2, the emergence of new variants raised doubts about the efficacy of the available vaccines. …”
    Get full text
    Article
  3. 1703
  4. 1704

    Leveraging mRNA technology for antigen based immuno-oncology therapies by Wei Zheng, Michele Ceccarelli, Charalampos S Floudas, Siranush Sarkizova

    Published 2025-01-01
    “…While this review centers on therapeutic mRNA vaccines targeting existing tumors, it does not cover preventative vaccines. …”
    Get full text
    Article
  5. 1705
  6. 1706
  7. 1707

    Self-replicating recombinant virus-like particles of lentivirus proliferating in glioblastoma cells and normal human macrophages by Herman D. Moshkoff, Andrey E. Moshkoff, Dmitry A. Moshkoff

    Published 2024-11-01
    “…Both attenuated and inactivated vaccines are used in disease control. Inactivated vaccines are very diverse and include whole cell and acellular vaccines containing protein target antigens or nucleic acids encoding target antigens. …”
    Get full text
    Article
  8. 1708

    Genotype Diversity of Newcastle Disease Virus in Nigeria: Disease Control Challenges and Future Outlook by Muhammad Bashir Bello, Khatijah Mohd Yusoff, Aini Ideris, Mohd Hair-Bejo, Ben P. H. Peeters, Abdurrahman Hassan Jibril, Farouk Muhammad Tambuwal, Abdul Rahman Omar

    Published 2018-01-01
    “…We then discuss the challenges of ND control as a result of the wide genetic distance between the currently circulating NDV isolates and the commonest vaccines used to combat the disease in the country. …”
    Get full text
    Article
  9. 1709
  10. 1710

    Antigen Gene Transfer to Human Plasmacytoid Dendritic Cells Using Recombinant Adenovirus and Vaccinia Virus Vectors by Hetty J. Bontkes, Janneke J. Ruizendaal, Marco W. J. Schreurs, Duco Kramer, Chris J. L. M. Meijer, Erik Hooijberg

    Published 2005-01-01
    “…Recombinant adenoviruses (RAd) and recombinant vaccinia viruses (RVV) expressing tumour-associated antigens (TAA) are used as anti-tumour vaccines. It is important that these vaccines deliver the TAA to dendritic cells (DC) for the induction of a strong immune response. …”
    Get full text
    Article
  11. 1711
  12. 1712
  13. 1713
  14. 1714
  15. 1715
  16. 1716

    COVID-19: An Update on the Latest Therapeutic Agents by Ke-Yan Loo, Loh Teng-Hern Tan, Jodi Woan-Fei Law, Kar-Wai Hong, Kok-Gan Chan, Vengadesh Letchumanan

    Published 2023-04-01
    “…Vaccines against the viral infection started rolling out in late 2020, and the distribution of the vaccines worldwide managed to reduce the symptoms of COVID-19 and prevent outbreaks in local communities. …”
    Get full text
    Article
  17. 1717

    Canada’s National Advisory Committee on Immunization: Celebrating 50 Years by Shalini Desai, Shainoor J lsmail, Robert Lerch, Bryna F Warshawsky, Ian Gemmill

    Published 2015-01-01
    “…Vaccines have saved more lives than any other innovation in modern medicine. …”
    Get full text
    Article
  18. 1718

    Advances in Immunotherapy for Melanoma: A Comprehensive Review by Carmen Rodríguez-Cerdeira, Miguel Carnero Gregorio, Adriana López-Barcenas, Elena Sánchez-Blanco, Beatriz Sánchez-Blanco, Gabriella Fabbrocini, Brunilda Bardhi, Ardiana Sinani, Roberto Arenas Guzman

    Published 2017-01-01
    “…Several types of vaccines, including peptide, viral, and dendritic cell vaccines, are currently under investigation for the treatment of melanoma. …”
    Get full text
    Article
  19. 1719
  20. 1720